SPARKLE BYTE LTD 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-20 11:40 am Purchase |
2022-12-02 | 13D | CASI Pharmaceuticals, Inc. CASI |
SPARKLE BYTE LTD | 1,019,852 7.600% |
0 (+0.00%) |
Filing |